Kalaris Therapeutics, Inc. (NASDAQ:KLRS) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Srinivas Akkaraju Other companies: Alumis Inc. (Founder and Managing Member, Samsara BioCapital · Since at least Jun 27, 2024); vTv Therapeutics Inc. (Director · Since at least Feb 23, 2024); Mineralys Therapeutics, Inc. (Board Member · Since at least Feb 9, 2023); Scholar Rock Holding Corporation (Director · Since at least Jul 26, 2022); Jiya Acquisition Corp (Director · Sep 23, 2022 – Sep 23, 2022 · Past); Syros Pharmaceuticals, Inc. (Director · Jun 1, 2022 – Sep 16, 2024 · Past); Aduro Biotech Inc (Director · May 26, 2022 – Aug 11, 2023 · Past); Intercept Pharmaceuticals Inc (Director · May 25, 2022 – Nov 8, 2023 · Past) | Director · Since at least Mar 18, 2025 |
| Ansbert Gadicke Other companies: Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Jun 22, 2022 · Past); Iteos Therapeutics Inc (Director · Jul 23, 2020 – Jul 28, 2020 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Jun 1, 2023 · Past); Chiasma Inc (Director · Jul 15, 2015 – Jun 9, 2016 · Past); Verastem, Inc. (Director · Jan 26, 2012 – Mar 6, 2012 · Past); Radius Health, Inc. (Director · May 17, 2011 – Feb 17, 2017 · Past) | Director · Jul 29, 2020 – Jul 28, 2022 · Past |
| Shawn Tomasello Other companies: Cabaletta Bio, Inc. (Director · Since at least Jul 21, 2023); 4D Molecular Therapeutics, Inc. (Director · Since at least Dec 10, 2020); Gamida Cell Ltd (Director · Jan 1, 2022 – Jan 31, 2024 · Past); UroGen Pharma Ltd. (Director · Jun 7, 2021 – Jun 7, 2021 · Past); Tcr2 Therapeutics Inc (Director · Feb 3, 2021 – Jun 1, 2023 · Past) | Director · Mar 29, 2022 – Jun 6, 2024 · Past |
| Laurie Keating Other companies: PepGen Inc. (Director · Since at least May 5, 2022); Immuneering Corporation (Director · Since at least Jul 29, 2021); Imago Biosciences Inc (Director · Nov 17, 2021 – Jan 11, 2023 · Past); Alnylam Pharmaceuticals, Inc. (EVP, Chief Legal Officer · Jan 11, 2021 – Aug 5, 2021 · Past) | Director · Since at least Jul 6, 2026 |
| Leone Patterson Other companies: Zymeworks Inc. (EVP, Chief Bus & Fin Officer · Since at least Sep 1, 2024); Nkarta, Inc. (Director · Since at least Jun 8, 2022); Tenaya Therapeutics, Inc. (Chief Fin. and Bus. Officer · Feb 15, 2023 – Feb 23, 2024 · Past); Climb Bio, Inc. (Director · May 19, 2022 – May 19, 2022 · Past) | Director · Since at least Apr 3, 2025 |
| Michael Dybbs Other companies: SpyGlass Pharma, Inc. (Director · Since at least Feb 5, 2026); Nkarta, Inc. (Director · Since at least Jul 9, 2020); Sutro Biopharma, Inc. (Member, Board of Directors · Since at least Sep 26, 2018); Dimension Therapeutics (Director · Oct 21, 2015 – Nov 7, 2017 · Past) | Director · Since at least Mar 18, 2025 |
| Vikas Sinha Other companies: Scholar Rock Holding Corporation (Chief Financial Officer · Since at least Apr 27, 2025); Verona Pharma plc (Director · Since at least Jan 1, 2021); BCLS Acquisition Corp (Director · Oct 22, 2020 – Oct 22, 2020 · Past); Alexion Pharmaceuticals Inc (EVP & CFO · Jul 12, 2013 – Aug 8, 2016 · Past) | See Remarks, Director · Jul 29, 2020 – Feb 21, 2025 · Past |
| David L. Hallal Other companies: Scholar Rock Holding Corporation (Chairman and Chief Executive Officer · Since at least Jun 27, 2024); Iteos Therapeutics Inc (Director · Since at least Jun 11, 2024); Seer, Inc. (Director · Jun 12, 2024 – Jun 12, 2024 · Past) | Director · Since at least Jun 6, 2024 |
| Jeff Bornstein Other companies: Eos Energy Enterprises, Inc. (Director · Since at least Sep 7, 2022); SpringBig Holdings, Inc. (Director · Feb 11, 2021 – Feb 11, 2021 · Past); GE Aerospace (Vice Chairman · Jul 1, 2013 – Nov 6, 2017 · Past) | Director · Jul 29, 2020 – Jun 6, 2024 · Past |
| Matthew Gall Other companies: Tango Therapeutics, Inc. (Chief Financial Officer · Since at least Apr 15, 2026); Iteos Therapeutics Inc (Chief Financial Officer · Since at least Jul 23, 2020) | Chief Financial Officer · Since at least Nov 3, 2025 |
| Morana Jovan-Embiricos Other companies: Cullinan Therapeutics, Inc. (Director · Jan 7, 2021 – Sep 16, 2021 · Past); Tcr2 Therapeutics Inc (Director · Feb 13, 2019 – Feb 19, 2019 · Past) | Director · Since at least Jul 29, 2020 |
| Agustin Melian Other companies: Forma Therapeutics Holdings Inc (EVP, Research & Development · Jul 11, 2022 – Oct 14, 2022 · Past) | Chief Medical Officer · Jul 29, 2020 – Oct 4, 2021 · Past |
| Andrew Oxtoby Other companies: Aduro Biotech Inc (Chief Commercial Officer · Feb 15, 2023 – Aug 11, 2023 · Past) | CEO & Director · Since at least Mar 18, 2025 |
| Ann M Leen Other companies: Marker Therapeutics, Inc. (Chief Scientific Officer · Dec 21, 2018 – Feb 15, 2020 · Past) | Chief Scientific Officer · Jul 29, 2020 – Aug 16, 2022 · Past |
| Anthony Adamis Other companies: EyePoint, Inc. (Director · Jun 23, 2022 – Jun 23, 2024 · Past) | Director · Since at least Nov 8, 2024 |
| Brett R Hagen Other companies: Kineta Inc. (See Remarks · Aug 4, 2016 – Apr 3, 2017 · Past) | Chief Accounting Officer · Since at least Jul 29, 2020 |
| Edward Miller Other companies: Alexion Pharmaceuticals Inc (SVP, Chief Compliance Officer · Sep 9, 2016 – Feb 27, 2017 · Past) | General Counsel · Jul 29, 2020 – Feb 21, 2025 · Past |
| Jeroen B Van Beek Other companies: Tricida Inc (Chief Comm Officer and Sr VP · Jun 27, 2018 – Jul 2, 2018 · Past) | Chief Commercial Officer · Jul 29, 2020 – Nov 16, 2022 · Past |
| Juan F. Vera Other companies: Marker Therapeutics, Inc. (Chief Executive Officer & Co-Founder, Marker Therapeutics · Since at least Oct 17, 2018) | Director · Jul 29, 2020 – Jun 6, 2024 · Past |
| Mike Dybbs Other companies: Nkarta, Inc. (Director · Since at least Nov 4, 2026) | Director & Co-founder · Since at least Nov 8, 2024 |
| Napoleone Ferrara Other companies: TuHURA Biosciences, Inc. (Director · Apr 30, 2019 – Jun 26, 2020 · Past) | Director & Co-Founder · Since at least Mar 18, 2025 |
| Samir Chandrakant Patel Other companies: IVERIC bio Inc (President, Director · Sep 24, 2013 – Jan 4, 2017 · Past) | Director · Mar 18, 2025 – Apr 10, 2025 · Past |
| Amy O'Leary Vandekop | VP, Corporate Controller · Since at least Jul 27, 2026 |
| Liisa Bayko | CFO · Since at least Jul 20, 2026 |
| Malcolm Brenner | Director · Jul 29, 2020 – Jun 6, 2024 · Past |
| Matthew Feinsod | Chief Medical Officer · Since at least Mar 18, 2025 |